$300 Dacomitinib 45mg film-coated tablets pack of 30

Dacomitinib is a targeted therapy used primarily for treating non-small cell lung cancer. It focuses on the EGFR, which is the bad guy in this case, and it stops it from doing its thing. It’s for people with NSCLC who have either an EGFR exon 19 deletion or the L858R mutation in EGFR exon 21.

It is available in three dosage strengths: 15 mg, 30 mg, and 45 mg as film-coated tablets, with the recommended daily dose being 45 mg. Each medication is packaged in bottles containing 30 tablets per pack. It blocks the whole signaling thing that the EGFR starts, which in turn stops cancer cells from growing.

Dacomitinib can have some serious side effects, so it’s got to be started and watched closely by docs.